Molndal, Sweden

Li Lanna

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Albireo Ab. Active years: 2014-2015.

USPTO Granted Patents = 2 


Average Co-Inventor Count = 9.0

ph-index = 1


Location History:

  • Molndal, SE (2014)
  • Mölndal, SE (2015)

Company Filing History:


Years Active: 2014-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Li Lanna: Innovator in Pharmaceutical Chemistry

Introduction

Li Lanna is a prominent inventor based in Mölndal, Sweden. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating inflammatory conditions. With a total of 2 patents, her work is recognized for its potential impact on medical treatments.

Latest Patents

Li Lanna's latest patents focus on 2-substituted-3-phenylpropionic acid derivatives and their use in the treatment of inflammatory bowel disease. The inventions relate to various derivatives, including 2-(substituted sulphur, sulphone or sulphoxide)-3-(substituted phenyl)propionic acid derivatives, 2-(substituted oxygen)-3-(substituted phenyl)propionic acid derivatives, and benzoic acid derivatives. These compounds are designed for use in pharmaceutical compositions aimed at treating inflammatory conditions.

Career Highlights

Li Lanna is currently employed at Albireo AB, where she continues to advance her research in pharmaceutical innovations. Her work is characterized by a commitment to developing effective treatments for complex medical conditions.

Collaborations

Li collaborates with notable colleagues, including Anders Broo and Johan Gottfries, who contribute to her research efforts and enhance the innovative environment at Albireo AB.

Conclusion

Li Lanna's contributions to pharmaceutical chemistry exemplify the vital role of inventors in advancing medical science. Her innovative work in developing treatments for inflammatory conditions showcases her dedication to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…